SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-116917
Filing Date
2012-03-15
Accepted
2012-03-15 13:46:00
Documents
8
Period of Report
2012-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d316951d8k.htm 8-K 29412
2 CERTIFICATE OF DESIGNATION OF RIGHTS d316951dex31.htm EX-3.1 82240
3 STOCK PURCHASE AGREEMENT d316951dex101.htm EX-10.1 120922
4 AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT d316951dex102.htm EX-10.2 54233
5 MANAGEMENT RIGHTS LETTER d316951dex103.htm EX-10.3 10204
6 CONSULTING CONTRACT d316951dex104.htm EX-10.4 36930
7 AGREEMENT TO PROVIDE CONSULTING SERVICES WITH KENNETH C. ALDRICH d316951dex105.htm EX-10.5 19842
8 AGREEMENT TO PROVIDE CONSULTING SERVICES WITH JEFFREY D. JANUS d316951dex106.htm EX-10.6 19376
  Complete submission text file 0001193125-12-116917.txt   374620
Mailing Address 2595 JASON COURT OCEANSIDE CA 92056
Business Address 2595 JASON COURT OCEANSIDE CA 92056 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51891 | Film No.: 12693331
SIC: 2834 Pharmaceutical Preparations